Sexual Desire and Pharmacologic Management

Tami S. Rowen,James A. Simon
DOI: https://doi.org/10.1016/j.ogc.2024.03.004
IF: 2.838
2024-05-23
Obstetrics and Gynecology Clinics of North America
Abstract:• There are two FDA approved medication for low desire in premenopausal women. • Testosterone has been used off label for low desire in post menopausal women. • All sexual dysfcuntion should be viewed through a biopsychosocial lens. There are two FDA approved medication for low desire in premenopausal women. Testosterone has been used off label for low desire in post menopausal women. All sexual dysfcuntion should be viewed through a biopsychosocial lens. Female sexual health is a complex topic that involves numerous physiologic pathways that are relevant to the practicing health care provider. Sexual problems can be associated with distress, and include problems with desire, arousal, and orgasm affecting up to 12% of adult
obstetrics & gynecology
What problem does this paper attempt to address?